Colgate-Palmolive Seen Supported by Emerging Markets Growth, RBC Capital Markets Says

MT Newswires Live
07/29

Colgate-Palmolive (CL) is expected to continue benefiting from emerging markets growth as international strength offsets ongoing weakness in North America, RBC Capital Markets said in a Wednesday note.

The investment firm said it expects Colgate-Palmolive to report an in-line Q2 and reiterate its full-year sales and earnings guidance.

RBC also expects continued margin pressure this year but said Colgate's cost assumptions, including oil at about $110 per barrel, provide greater flexibility than some peers if input costs continue to rise.

The firm said management remains confident in sustaining its long-term 3% to 5% organic sales growth algorithm despite tariff, energy and consumer spending uncertainty.

RBC Capital Markets maintained its outperform rating on Colgate-Palmolive, with a $102 price target.

Price: 92.36, Change: -0.37, Percent Change: -0.40

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10